Suven Life Sciences Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Suven Life Sciences announces three poster presentations on Samelisant (SUVN-G3031), including global Phase-3, AWAKE Narcolepsy Study at the SLEEP-2026 Annual Meeting being held at Baltimore, USA".
Suven Life Sciences Limited Press Release Jun 12 2026
Earlier from Suven Life Sciences
- Suven Life Sciences: June 04, 2026Suven Life Sciences Reports Positive DSMB Safety Review and Interim Analysis from Ongoing Global Pha
- Press Release Jun 04 2026
- Press Release May 12 2026
- Press Release Dec 11 2025